Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
MELA SCIENCES (NQ: MELA)
0.8001 USD  -0.0283 (-3.42%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about MELA SCIENCES
 
< Previous 1 2 3 Next >
Joseph V. Gulfo Resigns as CEO of MELA Sciences; Robert C. Coradini Named Interim CEO; David Stone Elected Chairman of the Board
June 17, 2013
from GlobeNewswire News Releases
MELA Sciences, Inc. Rings NASDAQ Opening Bell With Leading Dermatologists To Raise Awareness For Melanoma Detection And Prevention
May 06, 2013
from PR Newswire
MELA Sciences Announces First Quarter 2013 Financial Results
April 30, 2013
from GlobeNewswire News Releases
MELA Sciences, Inc. Partners With Dermatologists Nationwide To Promote Skin Cancer Awareness
April 23, 2013
FREE MELAFIND® SESSIONS ON MAY 1 Read More
from PR Newswire
MELA Sciences to Host Investor Meeting in Conjunction With Melanoma Monday on May 6th 2013 in New York
April 18, 2013
from GlobeNewswire News Releases
MELA Sciences to Participate in Upcoming 12th Annual Needham Healthcare Conference
April 15, 2013
from GlobeNewswire News Releases
MELA Sciences to Release First Quarter 2013 Financial Results and Host Conference Call on Tuesday, April 30, 2013
April 10, 2013
from GlobeNewswire News Releases
MELA Sciences, Inc. Presents New Data That Reinforces The Importance Of MelaFind® As A Diagnostic Tool At AAD Meeting
March 18, 2013
Data Shows that MelaFind® Significantly Improves Melanoma Detection Rates of Resident Dermatologists Read More
from PR Newswire
Free Research Reports on ASTX, MELA, REE and VICL Issued by the Bedford Report
March 07, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
MELA Sciences Announces Fourth Quarter and Year End 2012 Financial Results
March 05, 2013
from GlobeNewswire News Releases
Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination
February 21, 2013
Survey Commissioned by MELA Sciences, Inc. Illustrates Need to Expand Skin Cancer Detection Habits in U.S. Read More
from PR Newswire
Free Research Reports on CIM, LFVN, MELA and UNIS Issued by the Bedford Report
February 13, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
MELA Sciences Prices Public Offering of Common Stock; Termination of At the Market (ATM) Equity Offering Program; and Execution of Term Sheet for Debt Financing
February 12, 2013
from GlobeNewswire News Releases
MELA Sciences to Release Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on Tuesday, March 5, 2013
February 04, 2013
from GlobeNewswire News Releases
Free Research Report on Lloyds Banking Group plc, MELA Sciences, Inc., Mentor Graphics Corp., Mizuho Financial Group Inc. and Manitex International, Inc.
January 31, 2013
from PR Newswire
MELA Sciences to Present at Upcoming Investor Conferences
January 28, 2013
from GlobeNewswire News Releases
MELA Sciences to Participate in Upcoming 15th Annual Needham Growth Conference
January 04, 2013
from PR Newswire
MELA Sciences Names Rpr Marketing Communications as its New Agency of Record
January 03, 2013
from PR Newswire
MELA Sciences to Participate in Upcoming Stephens Fall Investor Conference
November 09, 2012
from GlobeNewswire News Releases
MELA Sciences Announces Third Quarter 2012 Financial Results
November 07, 2012
from GlobeNewswire News Releases
MelaFind Chosen as One of Top 10 Medical Innovations for 2013 by Cleveland Clinic
November 05, 2012
Criteria for Inclusion are Significant Clinical Impact, High Probability of Commercial Success, and Significant Human Interest Read More
from GlobeNewswire News Releases
MELA Sciences to Release Third Quarter Financial Results and Host Conference Call on Wednesday, November 7, 2012
October 24, 2012
from GlobeNewswire News Releases
MELA Sciences Announces Second Quarter 2012 Financial Results
August 07, 2012
from Marketwired News Releases
MELA Sciences to Release Second Quarter Financial Results and Host Conference Call on Tuesday, August 7, 2012
July 25, 2012
from Marketwired News Releases
MELA Sciences Announces Positive Results of Impact of MelaFind in German Clinical Study
July 09, 2012
Highly Clinically and Statistically Significant Increases in Melanoma Detection Rates Observed for Dermatologists Incorporating MelaFind Output in Biopsy Decision-Making Process Read More
from Marketwired News Releases
American Business Awards Honors MELA Sciences With Two Silver Stevie Awards
June 19, 2012
MELA Sciences Receives Business Innovation of the Year Award and Dr. Joseph Gulfo Receives Maverick of the Year Award Read More
from Marketwired News Releases
Boston Scientific and MELA Sciences Look to Benefit From Plan to Speed Up FDA Reviews
May 25, 2012
Five Star Equities Provides Stock Research on Boston Scientific and MELA Sciences Read More
from Marketwired News Releases
MELA Sciences Announces First Quarter 2012 Financial Results
May 03, 2012
from Marketwired News Releases
MELA Sciences Named 2012 Bronze Edison Award Winner
April 27, 2012
MELA Sciences Wins at NYC Ceremony for Its Flagship Product, MelaFind; Awards Celebrate 25 Years of Honoring Innovators and Innovation Read More
from Marketwired News Releases
MELA Sciences to Present at the 37th Annual Deutsche Bank Health Care Conference
April 24, 2012
from Marketwired News Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here